SEARCH BY
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 38 |
| Sector: Life Science M&A | 6 of 14 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 15 of 21 |
| State: Colorado M&A | 1 of 2 |
| Country: United States M&A | 5 of 11 |
| Year: 2021 M&A | 4 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-24 |
Stragen Pharma
Geneva, Switzerland Stragen Pharma is a developer of hard-to-make, complex generic drugs for the treatment of patients with life-threatening conditions that require comprehensive care and monitoring, usually in intensive care units. Stragen Pharma was founded in 1990 and is based in Geneva, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-05 |
Xpress Biologics
Milmort, Belgium Xpress Biologics is a developer of expression systems and manufacturing processes for the production of plasmid DNA and protein therapeutics. Xpress Biologics was founded in 2014 and is based in Milmort, Belgium. |
Buy | - |
